164 related articles for article (PubMed ID: 7940788)
1. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
Kliem V; Repp H; Frei U
Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
[No Abstract] [Full Text] [Related]
2. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
[No Abstract] [Full Text] [Related]
3. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ
Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787
[No Abstract] [Full Text] [Related]
4. Reduction of immunosuppressive therapy after renal transplantation: a randomized study.
Heering P; Westhoff A; Ivens K; Kutkuhn B; Grabensee B
Transplant Proc; 1994 Oct; 26(5):2530-2. PubMed ID: 7940778
[No Abstract] [Full Text] [Related]
5. Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial.
First MR; Schroeder TJ; Michael A; Hariharan S; Weiskittel P; Alexander JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):591-4. PubMed ID: 8438428
[No Abstract] [Full Text] [Related]
6. Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine.
Opelz G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1289-90. PubMed ID: 8442115
[No Abstract] [Full Text] [Related]
7. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation.
Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040
[No Abstract] [Full Text] [Related]
8. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
9. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
10. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
[No Abstract] [Full Text] [Related]
11. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
Hiesse C; Rousseau P; Kriaa F; Larue JR; Charpentier B
Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
[No Abstract] [Full Text] [Related]
12. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
Sumethkul V; Jirasiritham S; Chiewsilp P
Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
[No Abstract] [Full Text] [Related]
13. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
Vanrenterghem Y; Peeters J
Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
[No Abstract] [Full Text] [Related]
14. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
[No Abstract] [Full Text] [Related]
15. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
Buchholz B; Korn A
Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
[No Abstract] [Full Text] [Related]
16. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.
Abramowicz D; Norman DJ; Goldman M; De Pauw L; Kinnaert P; Kahana L; Thistlethwaite JR; Shield CF; Monaco AP; Vanherweghem JL
Transplant Proc; 1995 Feb; 27(1):852-3. PubMed ID: 7879204
[No Abstract] [Full Text] [Related]
17. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
[TBL] [Abstract][Full Text] [Related]
18. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
Joss N; Rodger RS; McMillan MA; Junor BJ
Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
[TBL] [Abstract][Full Text] [Related]
19. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
20. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.
Howard RJ; Pfaff WW; Brunson ME; Ramos EL; Peterson JC; Croker BP; Scornik JC; Parris CJ; Fennell RS
Transplant Proc; 1993 Feb; 25(1 Pt 2):884. PubMed ID: 8442256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
